A statistical analysis provided a much better result and showed an OR of 1.03, which indicated no association between the CHAT rs3810950 polymorphism and the AD risk among non-ApoE ε4 carriers (OR = 1.03, P = 0.08, shown in Table 5B). Here, APOE is linked to Alzheimer disease.